ALIMERA SCIENCES, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.055 USD | +1.83% |
|
-6.71% | -29.17% |
| 14/05 | Transcript : Alimera Sciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 14/05 | Alimera Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 157M | - | - | - | |||
| 89.22B | ||||||
| 40.49B | ||||||
| 32.79B | ||||||
| 26.23B | ||||||
| 14.52B |
